Dallas-based MicroTransponder is looking to treat neurological conditions with its aired Vagus Nerve Stimulation, which is designed to help patients with tinnitus as well as stroke victims. The ...
"We are pleased with CMS's decision to assign the Vivistim procedure to New Technology APC 1580, ensuring appropriate reimbursement for this groundbreaking therapy," said Richard Foust, ...
Vivistim is an FDA-approved breakthrough device that works with the brain and body to make stroke rehabilitation therapy and daily activities more effective. AUSTIN, Texas, Jan. 16, 2026 (GLOBE ...
AUSTIN, Texas, Jan. 31, 2023 /PRNewswire/ -- MicroTransponder®, Inc. announces that the Centers for Medicare and Medicaid Services (CMS) awarded the Vivistim® Paired VNS™ System transitional ...
AUSTIN, Texas, Jan. 16, 2026 (GLOBE NEWSWIRE) -- MicroTransponder®, Inc., a commercial-stage medical technology company and developer of the breakthrough Vivistim® Paired VNS™ System for chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results